Harmony Biosciences Holdings, Inc.
(HRMY - NASDAQ)
31,05 USD
📋 Profilo Aziendale

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States.

|